针对老年患者选择和实施侵入性治疗策略的最新证据,这些老年患者非ST段升高心肌梗塞
Kieran Gill1, Vijay Kunadian2,3
1Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.
Heart (British Cardiac Society)
|February 12, 2025
概括
患有非ST段升高心肌梗塞 (NSTEMI) 的老年人从侵入性治疗中受益,减少心脏病发作和再血管化. 然而,这种方法并不能改善这一群体的死亡率.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 临床试验 临床试验
背景情况:
- 非ST段升高心肌梗塞 (NSTEMI) 在老年人 (≥75岁) 中很常见,与年轻患者相比,结果更差.
- 尽管指南建议全面考虑侵入性治疗,但由于试验证据有限,老年患者接受治疗的频率较低.
- 老年人群表现出显著的异质性,脆弱性,认知障碍和并发症使风险评估复杂化.
研究的目的:
- 审查有关NSTEMI老年人侵入性治疗的最新证据.
- 讨论老年综合征对该队列临床结果的影响.
- 为老年人NSTEMI管理提供个人风险评估和共享决策的信息.
主要方法:
- 审查最近的临床试验数据,包括SENIOR-RITA试验.
- 分析影响老年NSTEMI患者治疗决策的因素.
- 讨论脆弱性,并发症和认知障碍的作用.
主要成果:
- 老年NSTEMI患者的侵入性治疗是安全的.
- 它降低了非致命的心肌梗塞和随后的再血管化率.
- 在最近的试验中,死亡率的好处没有被证明.
结论:
- 个性化风险评估和共享决策对于老年人NSTEMI的管理至关重要.
- 侵入性策略提供了超出死亡率的好处,例如减少反复发生的事件.
- 需要进一步的研究来优化对这一脆弱群体的护理.
关键词:
急性冠状动脉综合征急性冠状动脉综合征冠状动脉动脉图 (Coronary Angiography) 是一种冠状动脉动脉图.冠状动脉疾病是一种冠状动脉疾病.心肌梗塞的心脏病发作通过皮肤进行冠状动脉干预.更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
4.8K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.3K
相关概念视频
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
